Registry for lead extraction from pacemakers and defibrillators
Official title: The Oregon Health & Science University Cardiac Implantable Electronic Device Extraction Registry
Run by Oregon Health and Science University · NCT03847025 · Data updated 2026-11-12
This study collects information from patients who have had lead extraction from their pacemakers and defibrillators to better understand the reasons for the procedure and its results.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Status | Recruiting |
| Started | September 2013 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | April 15, 2024 |
| Trial ID | NCT03847025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who are scheduled to undergo lead extraction of their pacemaker or defibrillator.
✕Probably not a fit
Patients who do not require lead extraction or are not undergoing the procedure will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects and analyzes data from patients who have undergone lead extraction procedures for pacemakers and implantable cardioverter defibrillators at Oregon Health and Science University. The study focuses on patient characteristics, procedural specifications, indications for lead extraction, and outcomes. By compiling this data into a comprehensive database, the research aims to enhance understanding of the factors influencing lead extraction and its associated complications.
Why it matters
Potential benefit: If successful, this registry could improve patient outcomes by identifying best practices and risk factors associated with lead extraction procedures.
How similar studies have gone: While observational studies on lead extraction exist, this registry approach is relatively novel in its comprehensive data collection and analysis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Undergoing lead extraction Exclusion Criteria: * registry--n/a
Where it's running
-
Charles Henrikson
Portland, Oregon, United States Recruiting
Study contacts
- Principal investigator: Charles Henrikson, MD — 503-494-0331
- Study coordinator: Charles Henrikson, MD
- Email: henrikso@ohsu.edu
- Phone: 503-494-0331
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Topical ruxolitinib for adults with pyoderma gangrenosum
This pilot study tests a topical cream of ruxolitinib to see if it helps heal PG ulcers in adults without adding systemic immunosuppressants.
-
Bright light therapy to help sleep after brain injury
This trial tests whether morning bright light therapy can improve sleep and related brain health markers in adults with a traumatic brain injury.
-
Transitioning from mavacamten to aficamten in obstructive HCM
This study tests whether switching from mavacamten to aficamten is feasible and safe for people with obstructive hypertrophic cardiomyopathy who are already on mavacamten.
-
Motor Activation Therapy after concussion: a targeted rehabilitation approach
This study tests a motor-activation focused physical therapy for people with persistent balance problems after a concussion to see if it improves their responses to imbalance.
-
L-fucose supplementation for adults with GLUT1 deficiency
This trial will test whether taking L-fucose supplements helps reduce ataxia and other symptoms in adults with GLUT1 deficiency.
-
Cefotetan Therapy for E. coli Infections
This pilot study tests whether cefotetan works for bloodstream infections caused by E. coli, compared with standard antibiotics, to see if it improves outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.